StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Elutia's price to book ratio was 2.7× on Nov 11, 2026, against 10.7× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×−8.6
2022Jul 29, 202211.3×–

More Elutia figures

See a number that looks wrong?